Arcturus Therapeutics Holdings Inc. (ARCT) vs Fennec Pharmaceuticals Inc. (FENC)
A side-by-side comparison of Arcturus Therapeutics Holdings Inc. and Fennec Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARCT
Arcturus Therapeutics Holdings Inc.
$13.14HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
FENC
Fennec Pharmaceuticals Inc.
$10.26HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
Total return — ARCT vs FENC
growth of $100 · dividends reinvested · last 9yARCT +87.0% (+7.2%/yr)FENC -11.5% (-1.3%/yr)ARCT compounded faster over this window
ARCT FENC
ARCT vs FENC: by the numbers
- •ARCT is the larger company ($373M vs $356M market cap).
- •Both run net losses; FENC's is the smaller (-5.49% vs -391.90% net margin).
- •FENC grew revenue faster over the past five years (222.46% vs 22.30% CAGR).
Metrics side by side
Valuation
| Metric | ARCT | FENC |
|---|---|---|
| Forward P/E | N/A | 36.19 |
| P/S ratio | 15.69 | 6.02 |
| P/B ratio | 2.17 | 8.39 |
Profitability
| Metric | ARCT | FENC |
|---|---|---|
| Gross margin | 95.50% | 93.73% |
| Operating margin | -111.51% | -14.22% |
| Net margin | -391.90% | -5.49% |
| ROE | -54.29% | -7.66% |
| ROIC | -54.07% | -1.84% |
Growth (annualized)
| Metric | ARCT | FENC |
|---|---|---|
| Revenue CAGR (5Y) | 22.30% | 222.46% |
| Total return CAGR (5Y) | -18.73% | 2.45% |
Frequently asked
- Which has grown faster, ARCT or FENC?
- Over the past five years, FENC grew revenue faster — ARCT at a 22.30% CAGR versus FENC at 222.46%.
- How have ARCT and FENC total returns compared?
- Over the past 5 years, ARCT delivered -18.73% and FENC delivered 2.45% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Arcturus Therapeutics ROEFennec Pharmaceuticals ROEArcturus Therapeutics operating marginFennec Pharmaceuticals operating marginArcturus Therapeutics revenue growthFennec Pharmaceuticals revenue growthArcturus Therapeutics free cash flowFennec Pharmaceuticals free cash flow
Arcturus Therapeutics & Fennec Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.